Algés, Oeiras Mon to Fri · 09:00 to 13:00 and 14:00 to 19:00 · Sat · 09:00 to 14:00
WhatsApp Book a consultation
  1. Home
  2. Aesthetic gynaecology
  3. Intimate fissures
  4. Vulval lichen sclerosus

Lichen sclerosus: the vulvar condition many women have never heard of

Itching that does not go away, white skin and fissures that keep returning may be lichen sclerosus, a chronic, non-contagious disease of the vulva, with effective treatment that requires follow-up.

Luxmed TeamAuthor
Dr Michelle CampagnoliClinical review · OM no. 69467
8 min read
Foto de capa · a do cartão do blog1200 × 800 px (3:2)
Quando existir, entra aqui e também no cartão da página do blog.
In this article
  1. In short
  2. What it is
  3. Who it affects
  4. Causes
  5. Symptoms
  6. Diagnosis
  7. Treatment
  8. Follow-up and cancer risk
  9. When to see a doctor
  10. At Luxmed Clinic
  11. Frequently asked questions

Itching of the vulva that does not go away, whiter skin, fissures that keep coming back: many women with lichen sclerosus spend years treating "thrush" or "irritation" before receiving the right diagnosis. The delay in diagnosis is estimated to be, on average, several years.

Lichen sclerosus is a chronic inflammatory skin disease, which mainly affects the vulva and the area around the anus. It is not contagious and is not an infection. It has effective treatment, but needs to be recognised, treated correctly and followed up over time.

In 30 seconds

Three ideas to remember.

1Chronic, non-contagious diseaseLichen sclerosus is a chronic inflammatory disease of the vulval skin. Typical symptoms are intense itching, white, thin and fragile skin, fissures and pain during sex.
2Effective treatment is availableFirst-line treatment is a very potent corticosteroid ointment used according to a regimen prescribed by the doctor.
3Follow-up is part of the treatmentWithout treatment, it can alter the anatomy of the vulva and slightly increases the risk of vulval cancer. Regular follow-up, even without symptoms, is part of the treatment.
Imagem opcional · abertura1200 × 800 px
Fica por baixo do resumo, se existir uma segunda foto.

What it is

Lichen sclerosus is a chronic inflammatory disease that affects the skin, especially in the genital and anal area. The inflammation makes the skin thinner, whiter and less elastic, and over time it can lead to scarring and changes in the shape of the vulva.

It can appear in other areas of the body, but in around 85% to 98% of cases it affects the anogenital region (Kirtschig, 2016).

Who it affects

  • It is more frequent in women than in men.
  • It has two peaks: before puberty, in girls, and especially in the perimenopause and postmenopause.
  • The true frequency is unknown, because many cases are not diagnosed.
  • Studies in gynaecology clinics point to about 1 in every 60 to 1 in every 70 women, and the frequency is higher in older women (Goldstein et al., 2005).

Causes

The exact cause is not known. The most studied factors are:

  • Autoimmunity: it is more frequent in women with other autoimmune diseases, such as thyroid disease, vitiligo or pernicious anaemia, and many have autoantibodies.
  • Genetics: there are cases in several members of the same family.
  • Local factors: friction, trauma and prolonged contact with urine may favour its onset or worsening.
  • Hormones: the fact that it is more common at times of low oestrogen suggests a hormonal influence, but hormonal treatment does not cure the disease.

It is not caused by poor hygiene and is not transmitted by sexual contact.

Symptoms

  • Itching: the most common symptom, often intense and worse at night.
  • Burning and pain, especially when there are fissures.
  • White, thin, shiny skin, sometimes with a crumpled-paper appearance, or with small blood spots (ecchymoses) from fragility.
  • Fissures, often around the clitoris, between the labia, at the posterior fourchette and around the anus. The white "figure-of-eight" pattern around the vulva and anus is characteristic.
  • Pain during sex (dyspareunia), from fissures or from narrowing of the vaginal entrance.
  • Pain or difficulty opening the bowels, when it affects the anal area.
  • Changes in anatomy, in more advanced stages: the labia minora may shrink or fuse with the labia majora, the clitoris may become covered by skin ("buried") and the vaginal entrance may narrow.

Some women have few symptoms, and the disease is only found at a routine consultation. The vagina itself is not usually affected.

Diagnosis

In most cases, a doctor experienced in diseases of the vulva can suspect the diagnosis by examination. Guidelines recommend confirming with a biopsy (a small fragment of skin, removed under local anaesthetic) especially when (Lewis et al., 2018, Kirtschig et al., 2015, RCOG, 2011):

  • the appearance is not typical;
  • there is no response to treatment;
  • there is a thickened area, a wound that does not heal or a lump;
  • second-line treatment is about to begin.

If possible, the biopsy should be performed before starting the corticosteroid, because treatment can alter the result. Tests for associated autoimmune diseases, including thyroid function tests, may also be warranted.

Treatment

Very potent topical corticosteroid

First-line treatment, recommended by European and British guidelines, is a very potent corticosteroid ointment (clobetasol propionate 0.05%) (Lewis et al., 2018, Kirtschig et al., 2015, van der Meijden et al., 2022, Chi et al., 2011). A commonly used regimen is:

  • once a day for 4 weeks;
  • every other day for 4 weeks;
  • twice a week for a further 4 weeks;
  • then, maintenance according to the response, often once or twice a week in the long term.

The dose is small (an amount the size of a fingertip for the whole affected area). When used in this way and under medical supervision, it is safe on the vulva, even for years. Fear of the effects of corticosteroids leads many women to use less than needed, and that allows the disease to progress.

The exact schedule should always be defined by the doctor. Do not use corticosteroid creams on the vulva without a diagnosis.

General care

  • Wash with water or a gentle soap substitute; avoid perfumed soaps, wipes and perfumed pads.
  • Use an emollient or barrier ointment regularly.
  • Avoid scratching; keep nails short and, if necessary, wear cotton gloves at night.
  • Prefer cotton underwear and avoid very tight clothing.
  • Use a lubricant during sex.

Other options

When the corticosteroid is not enough or is not tolerated, topical calcineurin inhibitors (such as tacrolimus) may be considered, always with monitoring; in many countries this use is off-label for this indication. If there are adhesions or narrowing of the vaginal entrance that make sex or urination difficult, surgery may be needed, but only once the disease is under control.

There are studies of laser treatment and platelet-rich plasma, but the evidence is still limited and these treatments do not replace corticosteroid treatment. Current guidelines do not recommend them as first-line alternatives.

Follow-up and cancer risk

Untreated vulval lichen sclerosus is associated with a risk of squamous cell carcinoma of the vulva estimated at around 2% to 5% over a lifetime. An Australian study of more than 500 women showed that regular corticosteroid treatment, maintained in the long term, is associated with a lower risk of cancer and scarring (Lee et al., 2015).

For this reason, the following are recommended:

  • a consultation 3 to 6 months after starting treatment;
  • then regular follow-up, at least annually, even without symptoms;
  • self-examination of the vulva with a mirror, once a month;
  • an earlier consultation if a wound that does not heal, a lump, a thickened area or symptoms that do not respond to treatment appear.

When to see a doctor

Book a consultation if

Tick what applies to you.

If you already have a diagnosis of lichen sclerosus, seek prompt assessment if a wound appears that does not heal within two to three weeks, a lump, a thickened or hardened area, or new and persistent pain. If in doubt, contact the SNS 24 line (808 24 24 24); in an emergency, call 112.

At Luxmed Clinic

At Luxmed Clinic, in Algés, we carefully assess complaints of itching, fissures and changes in the skin of the vulva. When lichen sclerosus is suspected, we explain the diagnosis, the tests needed and the treatment and follow-up plan, coordinating with dermatology whenever justified.

Talk to us

The assessment is a conversation, with no obligation. Tell us what concerns you and our team will reply.

info@luxmed.pt

This article is for information only and does not replace a medical assessment. Results vary from person to person.

Frequently asked questions

Is lichen sclerosus curable?

It is a chronic disease that does not usually disappear completely, but in the great majority of women it is well controlled with the right treatment, with relief of symptoms and a lower risk of complications.

Is it contagious? Can my partner catch it?

No. It is not an infection and is not passed on through sexual contact or in any other way.

Is it harmful to use a corticosteroid for so long?

On the vulva, potent corticosteroids used at the recommended dose and schedule are safe, even in the long term, provided there is medical follow-up. The risk of not treating is greater than the risk of the treatment.

Can I have sex?

Yes. With the disease under control, most women can have comfortable sex. A lubricant and skin care help. If there is narrowing of the vaginal entrance, there are possible treatments.

Does lichen sclerosus turn into cancer?

In the great majority of cases, no. The risk exists, but it is low and is reduced with regular treatment and follow-up. That is why it is important not to miss appointments.

Scientific references 8
  1. Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018;178(4):839-853. Guideline
  2. Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol. 2015;29(10):e1-e43. Guideline
  3. van der Meijden WI, Boffa MJ, ter Harmsel WA, et al. 2021 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2022;36(7):952-972. Guideline
  4. Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10):1061-1067. Artigo
  5. Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50(7):477-480. Artigo
  6. Kirtschig G. Lichen sclerosus: presentation, diagnosis and management. Dtsch Arztebl Int. 2016;113(19):337-343. Artigo
  7. Royal College of Obstetricians and Gynaecologists. The Management of Vulval Skin Disorders. Green-top Guideline No. 58. London: RCOG; 2011. Guideline
  8. Chi CC, Kirtschig G, Baldo M, et al. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011;(12):CD008240. Revisão Cochrane
Written byLuxmed Team
Clinical reviewDr Michelle CampagnoliOM no. 69467 · Doctor with Competence in Aesthetic Medicine.View profile →

Editing and development: Rúben Brito · Operial Development

Book a consultation

Book your consultation

Choose how you prefer to get in touch. We will arrange the assessment consultation with Dr Michelle Campagnoli.

Booking through the websiteAssessment consultationTalk to our assistant on WhatsApp and ask for the current price of the assessment.

New Life Miraflores, Algés · Office Center, R. Santa Teresa do Menino Jesus n.º 6, 9.º C, 1495-048

Your details are used only for this contact. Any treatment depends on a prior medical assessment.

Request an appointmentIt takes less than a minute.
Speciality
You do not need to go into detail. The doctor will talk to you during the consultation.
Request received. Our team will contact you as soon as possible.
CallAssistantAvailableBook